Co-Diagnostics, Inc.
Public company- Headquarters
- SALT LAKE CITY, Utah
- Ticker
- CODX
- CIK
- 0001692415
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CFOBrian Brown | Sep 4, 2026 | Departed |
| Executive Vice President of Finance and AccountingDaniel Bohrer | Sep 4, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- MERIT MEDICAL SYSTEMS INC
Senior Advisor departs: Neil W. Peterson
- DarioHealth Corp.
Chairman of the Board appointed: John R. Palumbo
- FRACTYL HEALTH, INC.
Class III director appointed: Michael Wartell
- FEMASYS INC
director departs: Kenneth D. Eichenbaum, M.D., M.S.E.
- Executive departure
CFO departs: Brian Brown
Brian Brown, Chief Financial Officer of Co-Diagnostics, Inc., departs the role, effective September 2, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 4, 2026Role: Chief Financial Officer
- Executive appointment
Executive Vice President of Finance and Accounting appointed: Daniel Bohrer
Daniel Bohrer was named Executive Vice President of Finance and Accounting of Co-Diagnostics, Inc., effective September 2, 2026. Daniel Bohrer succeeds Brian Brown. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 4, 2026Role: Executive Vice President of Finance and Accounting
Last verified Nov 8, 2026